After finishing at $1.98 in the prior trading day, Molecular Templates Inc (NASDAQ: MTEM) closed at $1.85, down -6.57%. In other words, the price has decreased by -$0.1400 from its previous closing price. On the day, 1757657 shares were traded.
Ratios:
Our goal is to gain a better understanding of MTEM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 0.97. In the meantime, Its Debt-to-Equity ratio is 2.90 whereas as Long-Term Debt/Eq ratio is at 2.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on April 21, 2021, initiated with a Buy rating and assigned the stock a target price of $12.
On February 01, 2021, UBS started tracking the stock assigning a Neutral rating and target price of $13.
On September 08, 2020, Jefferies started tracking the stock assigning a Buy rating and target price of $21.Jefferies initiated its Buy rating on September 08, 2020, with a $21 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’24 when BIOTECH TARGET N V bought 250,000 shares for $2.35 per share. The transaction valued at 587,500 led to the insider holds 1,279,820 shares of the business.
BIOTECH TARGET N V bought 4,255,319 shares of MTEM for $2,000,000 on Jul 17 ’23. The 10% Owner now owns 15,447,322 shares after completing the transaction at $0.47 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MTEM now has a Market Capitalization of 12.18M and an Enterprise Value of 12.89M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.17 while its Price-to-Book (P/B) ratio in mrq is 2.36. Its current Enterprise Value per Revenue stands at 0.24 whereas that against EBITDA is 11.07.
Stock Price History:
Over the past 52 weeks, MTEM has reached a high of $9.45, while it has fallen to a 52-week low of $1.68. The 50-Day Moving Average of the stock is 3.0724, while the 200-Day Moving Average is calculated to be 5.4552.
Shares Statistics:
The stock has traded on average 26.44K shares per day over the past 3-months and 256.22k shares per day over the last 10 days, according to various share statistics. A total of 5.37M shares are outstanding, with a floating share count of 2.95M. Insiders hold about 45.15% of the company’s shares, while institutions hold 50.57% stake in the company. Shares short for MTEM as of Mar 15, 2024 were 27.3k with a Short Ratio of 1.03, compared to 56.65k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.51% and a Short% of Float of 0.71%.
Earnings Estimates
Its stock is currently analyzed by 1 different market analysts. On average, analysts expect EPS of -$0.78 for the current quarter, with a high estimate of -$0.78 and a low estimate of -$0.78, while EPS last year was $2.85. The consensus estimate for the next quarter is -$0.47, with high estimates of -$0.47 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$3.25 and -$3.25 for the fiscal current year, implying an average EPS of -$3.25. EPS for the following year is -$3.93, with 1 analysts recommending between -$3.93 and -$3.93.
Revenue Estimates
1 analysts predict $5.9M in revenue for the current quarter. It ranges from a high estimate of $5.9M to a low estimate of $5.9M. As of the current estimate, Molecular Templates Inc’s year-ago sales were $2.25M, an estimated increase of 162.20% from the year-ago figure. For the next quarter, 1 analysts are estimating revenue of $6.13M, a decrease of -10.70% less than the figure of $162.20% in the same quarter last year. There is a high estimate of $6.13M for the next quarter, whereas the lowest estimate is $6.13M.
A total of 1 analysts have provided revenue estimates for MTEM’s current fiscal year. The highest revenue estimate was $12.7M, while the lowest revenue estimate was $12.7M, resulting in an average revenue estimate of $12.7M. In the same quarter a year ago, actual revenue was $57.31M, down -77.80% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $1.37M in the next fiscal year. The high estimate is $1.37M and the low estimate is $1.37M. The average revenue growth estimate for next year is down -89.20% from the average revenue estimate for this year.
